期刊文献+

卵巢癌患者外周血HDAC2、PD-L1蛋白及调节性T细胞水平与临床病理特征和预后的关系分析

Analysis of the relationship between peripheral blood histone deacetylase 2,programmed death ligand 1 protein,and regulatory T-cell levels with clinicopathological features and prognosis in patients with ovarian cancer
下载PDF
导出
摘要 目的探讨卵巢癌(OC)患者外周血组蛋白脱乙酰基酶(HDAC2)、程序性死亡配体1(PD-L1)蛋白及调节性T细胞(Treg)水平与临床病理特征和预后的关系。方法选取2018年7月至2019年9月在张家口市第一医院确诊治疗的60例OC患者作为研究组,根据随访3年患者生存情况分为生存组(n=43)、死亡组(n=17);另选取同期同一医院确诊的60例卵巢良性肿瘤患者作为对照组。采用流式细胞术检测外周血Treg、辅助性T细胞17(Th17)和Th17/Treg水平,采用酶联免疫吸附试验法检测HDAC2和PD-L1蛋白水平。分析Treg、Th17、Th17/Treg、HDAC2和PD-L1蛋白水平与临床病理特征间的关系;治疗后随访3年,分析比较生存组和死亡组患者外周血Treg、Th17、Th17/Treg、HDAC2和PD-L1蛋白水平;采用Logistic回归分析OC患者预后的影响因素。结果研究组患者Treg、Th17、Th17/Treg、HDAC2和PD-L1水平均显著高于对照组(P<0.05);OCⅠ期、Ⅱ期、Ⅲ期和Ⅳ期患者Treg、Th17、Th17/Treg、HDAC2和PD-L1蛋白水平均依次升高,差异具有统计学意义(P<0.05)。临床分期、残存病灶大小、淋巴结转移、Treg、Th17、Th17/Treg、HDAC2和PD-L1蛋白水平均为OC患者预后的影响因素(P<0.05)。结论Treg、Th17、Th17/Treg、HDAC2和PD-L1蛋白参与并影响OC的发展,与患者预后密切相关。 Objective To investigate the relationship between the detection of peripheral blood histone deacetylase 2(HDAC2)and programmed death ligand 1(PD-L1)protein and regulatory T-cell(Treg)detection with clinicopathological features and prognosis in patients with ovarian cancer.Methods A total of 60 OC patients diagnosed and treated at Zhangjiakou First Hospital from July 2018 to September 2019 were selected as the study group.The patients were grouped into survival group(n=43)and death group(n=17)according to the 3-year follow-up of patients′survival condition.Another 60 patients with benign ovarian tumors diagnosed in the same hospital during the same time were selected as the control group.The levels of Treg,T helper cell 17(Th17)and Th17/Treg level in peripheral blood of all patients were detected by flow cytometry,the levels of HDAC2 and PD-L1 proteins were detected by enzyme-linked immunosorbent assay.The relationship between the levels of Treg,Th17,Th17/Treg,HDAC2 and PD-L1 proteins and the clinicopathological features was analyzed,the peripheral blood Treg,Th17,Th17/Treg,HDAC2,and PD-L1 protein levels were analyzed and compared between the survival group and the death group after follow-up for 3 years after treatment.Logistic regression was applied to analyze the factors influencing the prognosis of OC patients.Results The levels of Treg,Th17,Th17/Treg,HDAC2 and PD-L1 in patients in the study group were significantly higher than those in the control group(P<0.05).The levels of Treg,Th17,Th17/Treg,HDAC2 and PD-L1 proteins in OC patients in stage I,stage II,stage III and stage IV increased successively,and the difference was statistically obvious(P<0.05).The clinical stage,residual lesion size,lymph node metastasis,Treg,Th17,Th17/Treg,HDAC2 and PD-L1 proteins levels were all influencing factors for the prognosis of OC patients(P<0.05).Conclusions Treg,Th17,Th17/Treg,HDAC2 and PD-L1 proteins participate in and affect the development of OC,which are closely related to the prognosis of patients.
作者 王丽 王亚辉 景雅超 武洁 王霞 WANG Li;WANG Yahui;JING Yachao;WU Jie;WANG Xia(Department of Obstetrics and Gynecology,Zhangjiakou First Hospital,Zhangjiakou 075000,Hebei,China;Department of Pathology,Luannan County Hospital,Tangshan 063700,Hebei,China;Department of Infectious Diseases,the 81 st Group Military Hospital,Zhangjiakou 075000,Hebei,China)
出处 《中国性科学》 2024年第4期96-100,共5页 Chinese Journal of Human Sexuality
基金 河北省卫生健康委科研基金项目(20221897)。
关键词 卵巢癌 组蛋白脱乙酰基酶 程序性死亡配体1 调节性T细胞 辅助性T细胞17 预后 Ovarian cancer Histone deacetylase 2 Programmed death ligand 1 Regulatory T-cell T helper cell 17 Prognosis
  • 相关文献

参考文献14

二级参考文献66

  • 1薛春燕,谢荃沁,徐云,徐斌,张大川,糜亚琴,蒋敬庭.PD-L1和PD-L2在卵巢癌组织中的表达及对患者预后判断的价值[J].现代免疫学,2020,40(1):1-8. 被引量:8
  • 2伍丽,黄健容,兰易,朱晓芳.CEA、CA199和CA125单独和联合应用在卵巢癌诊断中的效能分析[J].中国妇产科临床杂志,2020,0(1):56-57. 被引量:42
  • 3肖德胜,李景和,文继舫,胡忠良,傅春燕.Western blot检测蛋白表达方法的改进[J].临床与实验病理学杂志,2003,19(2):210-211. 被引量:14
  • 4李山,秦雪,何卫华.血清CA125在卵巢癌诊断中的价值及文献评价[J].中华检验医学杂志,2005,28(2):209-211. 被引量:37
  • 5Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarianorigin of epithelial ovarian cancer - shifting the paradigm [ J ].Hum Pathol, 2011, 42(7):918-931.
  • 6Piek JM, van Diest PJ, Zweemer RP, et al. Dysplastic changes inprophylactically removed fallopian tubes of women predisposed todeveloping ovarian cancer [ J]. J Pathol, 2001,195(4) :451 -456.
  • 7Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tubemalignancies in BRCA - positive women undergoing surgery for o-varian cancer risk reduction [ J ]. J of Clin Oncol,2007,25(25):3985 -3990.
  • 8Kindelberger DW, Lee Y,Miron A,et al. Intraepithelial carcino-ma of the fimbria and pelvic serous carcinoma : evidence for acausal relationship [J]. Am J Surg Pathol, 2007, 31(2) :161 -169.
  • 9Crum CP, Herfs M,Ning G, et al. Through the glass darkly : in-traepithelial neoplasia,top - down differentiation, and the road toovarian cancer [J]. J Pathol, 2013,231 (4) :402 -412.
  • 10Seidman JD, Yemelyanova AV, Khedmati F, et al. Prognosticfactors for stage I ovarian carcinoma [ J] . Int J Gynecol Pathol,2010,29(1) :1 -7.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部